CompoAtlas

V-NAL

Food supplement declared in France, declaration No 2020-6-308

V-NAL (BI-ONAL) is a food supplement declared in France. Status: retiré du marché le 31 October 2023. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
BI-ONAL
Food business operator placing the product on the market
BIOXYDIET FRANCE SAS
Status
Retiré du marché le 31 October 2023
Form
Capsule
Daily dose
1 capsule
Directions for use
Prendre 1 capsule par jour avec un peu d'eau
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Circulation sanguine et lymphatique

Declaration 305257, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Aesculus hippocastanum L.GraineExtrait sec hydroalcoolique210 mg
Vitis vinifera L.FeuilleExtrait sec aqueux120 mg
Ruscus aculeatus L.RacineExtrait sec hydroalcoolique70 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg

Additives

E422, E420, E551, E901, E322, E172, E141

Other ingredients

huile de soja, gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Tenir hors de portée des jeunes enfants. Ne pas dépasser la dose journalière recommandée. Un complément alimentaire ne doit pas se substituer à une alimentation variée et équilibrée et à un mode de vie sain. Une consommation excessive peut avoir des effets laxatifs. L’emploi chez les femmes enceintes et allaitantes est déconseillé. L’emploi chez les personnes sous traitement anticoagulant est déconseillé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : BI-ONAL

Enter to analyse, Shift+Enter for a new line